A release said that Covaxin has been demonstrated in clinical trials to generate a broader immune response "against the whole virus covering important antigens such as S-protein, RBD, and N-protein whereas currently approved vaccines in the US target only S-protein antigen"
Washington [US], December 1 (ANI): A measles-virus-based COVID-19 vaccine might be able to prevent both COVID-19 and measles, according to a new study.